"What is often forgotten in this discussion is that serious injury or death, resulting from missing a potentially life-threatening diagnosis if no imaging is performed is a much greater, more imminent, and very real risk," he said.
In its statement, the FDA said wants to boost efforts to develop at least one national registry of radiation doses that will capture information from a variety of imaging studies that can be used to establish benchmarks for health care facilities to use with patients.
The ACR launched a similar registry about a year ago, according to spokesman Shawn Farley. The database is intended as a guide so a radiologist can quickly see how levels of radiation delivered in other practices and hospitals compare to what he or she is delivering.
"Now that the FDA has come out in favor of doing that, we're hoping that will put a little more weight behind the process and make more facilities want to take part in this," Farley told MedPage Today.
The FDA will hold a public meeting March 30 and 31 to hear comments on what types of safety requirements to establish for manufacturers of CT and fluoroscopic devices. Requirements might include:
That the radiation device display, record, and report equipment settings and radiation dose
Alerting users when the dose exceeds the optimal dose for most patients
Increased training for users
Ability to capture and transmit radiation dose information to a patient's electronic medical record in addition to national dose registries
This article was developed in collaboration with ABC News.